Connect Biopharma Holdings Limited (CNTB) annual balance sheet — 7-year assets, liabilities & equity history
| Total Current Assets | 50.93M | 96.96M | 122.55M | 155.78M | 275.13M | 24.78M | 7.52M |
| Cash & Short-Term Investments | 44.34M | 93.71M | 118.3M | 152.42M | 267.72M | 23.99M | 7.04M |
| Cash Only | 38.34M | 78.23M | 105.66M | 79.01M | 267.72M | 23.68M | 6.41M |
| Short-Term Investments | 6M | 15.48M | 12.64M | 73.41M | 0 | 306.41K | 635.15K |
| Accounts Receivable | 161K | 1.05M | 351K | 232K | 7.41M | 40.59K | 25.11K |
| Days Sales Outstanding | 918.2 | 14.74 | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 29K | 419K | 54K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 5.15M | 4.32M | 4.82M | 18.23M | 15.93M | 658.17K | 202.7K |
| Property, Plant & Equipment | 4.46M | 4.24M | 4.74M | 5.38M | 9.44M | 184.49K | 70.95K |
| Fixed Asset Turnover | 0.01x | 6.14x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 45K | 53K | 62K | 3.17M | 3.54M | 8.02K | 0 |
| Long-Term Investments | 0 | 0 | 0 | 9.44M | 0 | 0 | 0 |
| Other Non-Current Assets | 646K | 33K | 24K | 252K | 2.95M | 465.67K | 131.75K |
| Total Assets | 56.08M | 101.28M | 127.38M | 174.01M | 291.05M | 25.44M | 7.73M |
| Asset Turnover | 0.00x | 0.26x | - | - | - | - | - |
| Asset Growth % | -44.64% | -20.48% | -26.8% | -40.21% | 1044.19% | 229.27% | - |
| Total Current Liabilities | 13.61M | 8.46M | 25.29M | 15.62M | 17.98M | 890.94K | 568.07K |
| Accounts Payable | 1.96M | 342K | 2.21M | 11.94M | 12.73M | 577.7K | 472.5K |
| Days Payables Outstanding | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 167K | 164K | 13.32M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.91M | 3.34M | 2.05M | 0 | 0 | 0 | 0 |
| Current Ratio | 3.74x | 11.46x | 4.85x | 9.97x | 15.30x | 27.81x | 13.24x |
| Quick Ratio | 3.74x | 11.46x | 4.85x | 9.97x | 15.30x | 27.81x | 13.24x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 482K | 656K | 585K | 897K | 810K | 48.58M | 13.34M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 368K | 24K | 180K | 245K | 26K | 7.25K | 9.74K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 114K | 632K | 0 | 0 | 0 | 48.57M | 13.33M |
| Total Liabilities | 14.1M | 9.12M | 25.88M | 16.52M | 18.8M | 49.47M | 13.91M |
| Total Debt | 690K | 178K | 465K | 431K | 125K | 21.41K | 18.29K |
| Net Debt | -37.66M | -78.05M | -105.2M | -78.58M | -267.59M | -23.66M | -6.39M |
| Debt / Equity | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -5599.66x | -29235.62x | -4708.64x | -2080.02x |
| Total Equity | 41.98M | 92.17M | 101.5M | 157.49M | 272.26M | -24.03M | -6.18M |
| Equity Growth % | -54.45% | -9.19% | -35.55% | -42.15% | 1232.88% | -288.57% | - |
| Book Value per Share | 0.75 | 1.67 | 1.84 | 2.86 | 5.21 | -0.45 | -0.11 |
| Total Shareholders' Equity | 41.98M | 92.17M | 101.5M | 157.49M | 272.26M | -24.03M | -6.18M |
| Common Stock | 10K | 10K | 10K | 10K | 10K | 563 | 435 |
| Retained Earnings | -400.83M | -345.36M | -329.73M | -479.84M | -361.75M | -25.12M | -6.06M |
| Treasury Stock | -180K | -180K | -180K | -180K | -180K | -70 | -21 |
| Accumulated OCI | -1.19M | -1.67M | -1.01M | -7.63M | -4.03M | -39.7K | -1.01M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CNTB stock.
As of 2025, Connect Biopharma Holdings Limited (CNTB) had total assets of $56.1M including $50.9M in current assets.
Connect Biopharma Holdings Limited (CNTB) carries total debt of $0.7M, offset by $44.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Connect Biopharma Holdings Limited (CNTB) has total shareholders' equity (book value) of $42.0M ($0.75 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Connect Biopharma Holdings Limited (CNTB) reported a current ratio of 3.74x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.